Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y)EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q)EBITDA for
Revenue for Q2 FY22 of INR 4,200 Million, a growth of 19.3% (y-o-y) and 2.9% (q-o-q) Revenue for H1 FY23 of INR 8281 Million, a growth of 22.7% (y-o-y)EBITDA for Q2 FY23 of INR 810 Million, a growth of 28.0% (y-o-y) and 7.2% (q-o-q)EBITDA for
To provide patients access to world-class treatment facilities and with a commitment to offering high-quality clinical care, HCG Cancer Hospital, Bengaluru, one of India’s largest dedicated cancer care Hospitals announced the launch of India’s first Varian Ethos™ therapy, an Artificial Intelligence (AI)-driven holistic solution designed
Imperative to focus on quality to serve the global community: Additional Secretary, MoHFW Accentuating the importance of healthcare digitisation, Dr R S Sharma, CEO, National Health Authority yesterday said that the initiative can bring several desirable attributes to the healthcare system.Addressing the FICCI HEAL 2022 (concluding day) Dr